Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Mogamulizumab for ATLL in Clinical Practice

Masaaki Sekine, MD, Masaki Takeuchi, MD, Takanori Toyama, MD, Kouichi Maeda, MD, Seiichi Sato, MD, Kiyoshi Yamashita, MD, PhD, Junzo Ishizaki, MD, Akizuki Keiichi, MD, Ayako Kamiunten, MD, Takuro Kameda, MD PhD, Kotaro Shide, MD PhD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD, PhD

Blood (2016) 128 (22): 2998.

https://doi.org/10.1182/blood.V128.22.2998.2998

Published: 2016

Journal Articles

Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells

Yasuyoshi Sugano, Masaki Takeuchi, Ayami Hirata, Hirokazu Matsushita, Toshio Kitamura, Minoru Tanaka, Atsushi Miyajima

Blood (2008) 111 (3): 1167–1172.

https://doi.org/10.1182/blood-2007-03-081554

Published: 2008

Includes: Supplemental data

Journal Articles

Junctional Adhesion Molecule-A (JAM-A/JAM-1/F11R) Marks Long-Term Repopulating Hematopoietic Stem Cells.

Yasuyoshi Sugano, Masaki Takeuchi, Ayami Hirata, Hirokazu Matsushita, Toshio Kitamura, Minoru Tanaka, Atsushi Miyajima

Blood (2007) 110 (11): 1270.

https://doi.org/10.1182/blood.V110.11.1270.1270

Published: 2007

Journal Articles

Two Distinct Precursors of Hematopoietic Stem Cells and Endothelial Progenitors Characterized by the PCLP1 Expression.

Izumi Onitsuka, Masaki Takeuchi, MD, Ph.D, Tomoya Okabe, Yoshiko Kamiya, Ayami Hirata, Ichiro Yahara, Ph.D, Atsushi Miyajima, Ph.D

Blood (2005) 106 (11): 2274.

https://doi.org/10.1182/blood.V106.11.2274.2274

Published: 2005

Journal Articles

Cultivation of aorta-gonad-mesonephros–derived hematopoietic stem cells in the fetal liver microenvironment amplifies long-term repopulating activity and enhances engraftment to the bone marrow

Masaki Takeuchi, Takashi Sekiguchi, Takahiko Hara, Taisei Kinoshita, Atsushi Miyajima

Blood (2002) 99 (4): 1190–1196.

https://doi.org/10.1182/blood.V99.4.1190

Published: 2002

NARROW

Mogamulizumab for ATLL in Clinical Practice

Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells

Junctional Adhesion Molecule-A (JAM-A/JAM-1/F11R) Marks Long-Term Repopulating Hematopoietic Stem Cells.

Two Distinct Precursors of Hematopoietic Stem Cells and Endothelial Progenitors Characterized by the PCLP1 Expression.

Cultivation of aorta-gonad-mesonephros–derived hematopoietic stem cells in the fetal liver microenvironment amplifies long-term repopulating activity and enhances engraftment to the bone marrow

Email alerts

ASH Publications

American Society of Hematology

Mogamulizumab for ATLL in Clinical Practice

Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells

Junctional Adhesion Molecule-A (JAM-A/JAM-1/F11R) Marks Long-Term Repopulating Hematopoietic Stem Cells.

Two Distinct Precursors of Hematopoietic Stem Cells and Endothelial Progenitors Characterized by the PCLP1 Expression.

Cultivation of aorta-gonad-mesonephros–derived hematopoietic stem cells in the fetal liver microenvironment amplifies long-term repopulating activity and enhances engraftment to the bone marrow

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only